ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 328410 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 328410; 2) Community: the network communities that were significantly associated with the response to NSC 328410; 3) Molecule: the relationships between components within communities and NSC 328410; 4) MDR: the compounds that were significantly associated with the NSC 328410.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.0209467683758286 0.69649669
NSC 610459 Camptothecin Derivative 0.0209467683758286 0.71316821
NSC 625500 Null 0.0209467683758286 -0.058240321
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0209467683758286 0.25879873
NSC 653846 Benzoic acid, 2-hydroxy-, 2-[(3,4-dimethoxyphenyl)(cyano) methyl]hyrazide 0.0209467683758286 0.40382968
NSC 653860 Null 0.0209467683758286 0.62800786
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0209467683758286 0.53977332
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0209467683758286 0.59317717
NSC 681635 Camptothecin Derivative 0.0209467683758286 0.59036958
NSC 685005 Null 0.0209467683758286 -0.11276203
Total:68  Current:30    [First] [Prev] [Next] [Last]